Literature DB >> 21453757

Neurotoxic (+)-methamphetamine treatment in rats increases brain-derived neurotrophic factor and tropomyosin receptor kinase B expression in multiple brain regions.

A A Braun1, N R Herring, T L Schaefer, A M Hemmerle, J W Dickerson, K B Seroogy, C V Vorhees, M T Williams.   

Abstract

Methamphetamine (MA) is an abused stimulant which can result in cognitive deficits and monoamine depletions. Animal models of neurotoxic MA exposure show reductions in dopamine, serotonin, and their associated transporters. MA abuse can result in long-term attention, working memory, and executive function deficits in humans and deficits in route-based egocentric learning, novel object recognition, and novel odor preference in rodents. MA has also been shown to affect brain-derived neurotrophic factor (BDNF) in humans and rodents. This experiment examined the effects of a MA binge dosing regimen (10 mg/kg x 4 at 2 h intervals, s.c.) in Sprague-Dawley rats on BDNF, tropomyosin receptor kinase B (TrkB), and tyrosine hydroxylase (TH) mRNA expression, and plasma corticosterone. Tissues were collected 1, 7, and 24 h following the last MA dose. Expression of BDNF and TrkB mRNA was analyzed using in situ hybridization with cRNA probes. Frontal, parietal, and entorhinal cortical BDNF mRNA expression were increased by MA exposure at all time-points. Increases in BDNF mRNA were also seen in the hippocampal CA1, prefrontal cortex (PFC), piriform cortex, and locus coeruleus but only at specific times. TrkB mRNA expression was modified in several subregions of the hippocampus as well as in PFC and striatum. TH mRNA was increased at the 1 h time-point in the substantia nigra pars compacta with no differences noted at the other times. Corticosterone levels were increased at all three time-points. The findings suggest that BDNF and its receptor may be upregulated as a compensatory mechanism after MA exposure.
Copyright © 2011 IBRO. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21453757      PMCID: PMC3100392          DOI: 10.1016/j.neuroscience.2011.03.045

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  83 in total

Review 1.  The need for speed: an update on methamphetamine addiction.

Authors:  Alasdair M Barr; William J Panenka; G William MacEwan; Allen E Thornton; Donna J Lang; William G Honer; Tania Lecomte
Journal:  J Psychiatry Neurosci       Date:  2006-09       Impact factor: 6.186

2.  Developmental expression of neurotrophins and their receptors in postnatal rat ventral midbrain.

Authors:  Suzanne Numan; Christine M Gall; Kim B Seroogy
Journal:  J Mol Neurosci       Date:  2005       Impact factor: 3.444

3.  Impaired object recognition memory following methamphetamine, but not p-chloroamphetamine- or d-amphetamine-induced neurotoxicity.

Authors:  Annabelle M Belcher; Steven J O'Dell; John F Marshall
Journal:  Neuropsychopharmacology       Date:  2005-11       Impact factor: 7.853

4.  A single cocaine exposure increases BDNF and D3 receptor expression: implications for drug-conditioning.

Authors:  Bernard Le Foll; Jorge Diaz; Pierre Sokoloff
Journal:  Neuroreport       Date:  2005-02-08       Impact factor: 1.837

5.  The effects of chronic administration of quetiapine on the methamphetamine-induced recognition memory impairment and dopaminergic terminal deficit in rats.

Authors:  Jue He; Yi Yang; Yingxin Yu; Xiaokun Li; Xin-Min Li
Journal:  Behav Brain Res       Date:  2006-05-19       Impact factor: 3.332

6.  Brain serotonin transporter density and aggression in abstinent methamphetamine abusers.

Authors:  Yoshimoto Sekine; Yasuomi Ouchi; Nori Takei; Etsuji Yoshikawa; Kazuhiko Nakamura; Masami Futatsubashi; Hiroyuki Okada; Yoshio Minabe; Katsuaki Suzuki; Yasuhide Iwata; Kenji J Tsuchiya; Hideo Tsukada; Masaomi Iyo; Norio Mori
Journal:  Arch Gen Psychiatry       Date:  2006-01

7.  Relation between methamphetamine-induced monoamine depletions in the striatum and sequential motor learning.

Authors:  David P Daberkow; Raymond P Kesner; Kristen A Keefe
Journal:  Pharmacol Biochem Behav       Date:  2005-05       Impact factor: 3.533

Review 8.  Implications of chronic methamphetamine use: a literature review.

Authors:  Charles W Meredith; Craig Jaffe; Kathleen Ang-Lee; Andrew J Saxon
Journal:  Harv Rev Psychiatry       Date:  2005 May-Jun       Impact factor: 3.732

9.  High concentrations of plasma brain-derived neurotrophic factor in methamphetamine users.

Authors:  Dai-Jin Kim; Sungwon Roh; Yujung Kim; Su-Jung Yoon; Hae-Kook Lee; Chang-Su Han; Yong-Ku Kim
Journal:  Neurosci Lett       Date:  2005-11-11       Impact factor: 3.046

10.  c-fos modulates brain-derived neurotrophic factor mRNA expression in mouse hippocampal CA3 and dentate gyrus neurons.

Authors:  Mei Dong; Yongfei Wu; Yunxia Fan; Ming Xu; Jianhua Zhang
Journal:  Neurosci Lett       Date:  2006-03-13       Impact factor: 3.046

View more
  12 in total

1.  (±)3,4-methylenedioxymethamphetamine ("ecstasy") treatment modulates expression of neurotrophins and their receptors in multiple regions of adult rat brain.

Authors:  Ann M Hemmerle; Jonathan W Dickerson; Nicole R Herring; Tori L Schaefer; Charles V Vorhees; Michael T Williams; Kim B Seroogy
Journal:  J Comp Neurol       Date:  2012-08-01       Impact factor: 3.215

2.  Effects of adolescent methamphetamine and nicotine exposure on behavioral performance and MAP-2 immunoreactivity in the nucleus accumbens of adolescent mice.

Authors:  Jordan M Buck; Alysse S Morris; Sydney J Weber; Jacob Raber; Jessica A Siegel
Journal:  Behav Brain Res       Date:  2017-01-12       Impact factor: 3.332

3.  A stress steroid triggers anxiety via increased expression of α4βδ GABAA receptors in methamphetamine dependence.

Authors:  H Shen; A Mohammad; J Ramroop; S S Smith
Journal:  Neuroscience       Date:  2013-08-29       Impact factor: 3.590

4.  Methamphetamine self-administration attenuates hippocampal serotonergic deficits: role of brain-derived neurotrophic factor.

Authors:  Lisa M McFadden; Paula L Vieira-Brock; Glen R Hanson; Annette E Fleckenstein
Journal:  Int J Neuropsychopharmacol       Date:  2014-03-20       Impact factor: 5.176

Review 5.  The role of astrocyte mitochondria in differential regional susceptibility to environmental neurotoxicants: tools for understanding neurodegeneration.

Authors:  Laura L Kubik; Martin A Philbert
Journal:  Toxicol Sci       Date:  2015-03       Impact factor: 4.849

6.  Neurochemical and behavioral comparisons of contingent and non-contingent methamphetamine exposure following binge or yoked long-access self-administration paradigms.

Authors:  Catherine A Schweppe; Caitlin Burzynski; Subramaniam Jayanthi; Bruce Ladenheim; Jean Lud Cadet; Eliot L Gardner; Zheng-Xiong Xi; Henriette van Praag; Amy Hauck Newman; Thomas M Keck
Journal:  Psychopharmacology (Berl)       Date:  2020-05-09       Impact factor: 4.530

7.  Methamphetamine augment HIV-1 Tat mediated memory deficits by altering the expression of synaptic proteins and neurotrophic factors.

Authors:  Anantha Ram Nookala; Daniel C Schwartz; Nitish S Chaudhari; Alexy Glazyrin; Edward B Stephens; Nancy E J Berman; Anil Kumar
Journal:  Brain Behav Immun       Date:  2018-05-02       Impact factor: 7.217

8.  MRI of neuronal recovery after low-dose methamphetamine treatment of traumatic brain injury in rats.

Authors:  Guang Liang Ding; Michael Chopp; David J Poulsen; Lian Li; Changsheng Qu; Qingjiang Li; Siamak P Nejad-Davarani; John S Budaj; Hongtao Wu; Asim Mahmood; Quan Jiang
Journal:  PLoS One       Date:  2013-04-18       Impact factor: 3.240

9.  Time-Dependent Serum Brain-Derived Neurotrophic Factor Decline During Methamphetamine Withdrawal.

Authors:  Wenwei Ren; Jingyan Tao; Youdan Wei; Hang Su; Jie Zhang; Ying Xie; Jun Guo; Xiangyang Zhang; Hailing Zhang; Jincai He
Journal:  Medicine (Baltimore)       Date:  2016-02       Impact factor: 1.889

10.  Psychological intervention with working memory training increases basal ganglia volume: A VBM study of inpatient treatment for methamphetamine use.

Authors:  S J Brooks; K H Burch; S A Maiorana; E Cocolas; H B Schioth; E K Nilsson; K Kamaloodien; D J Stein
Journal:  Neuroimage Clin       Date:  2016-08-24       Impact factor: 4.881

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.